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The global regulatory locus sarA comprises a 375-bp open reading frame that is driven by three promoters,
the proximal P1 and distal P3 and P2 promoters. We mutated the weaker P3 and P2 promoters to ascertain
the effect of the change on SarA protein and target gene expression. Our results indicated that the solely active
P1 promoter led to a lower SarA protein level, which has an effect on agr transcription and subsequently had
corresponding effects on hla, sspA, and spa transcription, probably in both agr-independent and agr-dependent
manners.

Temporal regulation of virulence determinants in Staphylococcus aureus has been shown to be under the control of global
regulators such as the two component regulatory systems and
the SarA protein family (2). The prototypic member of the
SarA protein family is the SarA protein, a 14.5-kDa DNAbinding protein that modulates the transcription of specific
regulatory loci (e.g., agr) (16), as well as downstream target
genes (e.g., the alpha-hemolysin and protein A genes) (5).
Indeed, transcriptional profiling studies by Dunman et al. (8)
demonstrated that the sarA locus probably controls target
genes both directly and indirectly (i.e., via other regulatory
loci). Accordingly, the expression of sarA and its effect on
target genes likely entail significant metabolic expenditure by
the bacteria. It is therefore not surprising that sarA expression
is tightly controlled during the growth cycle, presumably via
regulatory inputs to the sarA promoter (2).
Contrary to the terse promoters of many prokaryotic genes,
the sarA promoter region is extensive (⬃800 bp), comprising
three promoters (P2, P3, and P1) that yield three distinct
overlapping transcripts (sarA P2, P3, and P1 transcripts), each
encoding the SarA protein (Fig. 1) (1). The sarA P1 and P2
promoters are A dependent and are activated mostly during
the exponential phase, while the P3 promoter is B dependent
and is active postexponentially, coinciding with the maximal
predicted activity of B during periods of metabolic stress (4).
Embedded within the triple sarA promoter are both direct and
indirect repeats (13), thus leading us to initially theorize that
this region may constitute binding sites for regulatory proteins.
A subsequent search for DNA-binding proteins with a solidphase column containing the sarA promoter yielded SarR, a
homolog of SarA that binds predominantly to the sarA P1
promoter region (14). Transcriptional and immunoblot analyses disclosed that SarR likely represses the sarA promoter to
down-regulate SarA protein expression (14). Thus, SigB and

SarR can modulate SarA expression by differential binding to
the sarA promoter during growth (2).
Transcriptional analysis with XylE fusions divulged that the
sarA P1 promoter and the native P2-P3-P1 promoters are most
predominant (13). However, the contribution of the P2 and P3
promoters to the proximal P1 promoter has not been defined
(Fig. 1A). Interestingly, a potential smaller coding region
nested within the P3-P1 promoter (previously designated open
reading frame 3 [ORF3]) has been shown to modulate sarA
expression (Fig. 1) (3, 7). To dissect the contribution of the P2
and P3 promoters and to ascertain the role of the putative
ORF3 sequence in sarA expression (13), we undertook in this
study a mutational analysis of the sarA promoter. We introduced single copies into the staphylococcal chromosome of an
orf3 sarA deletion mutant, focusing in particular on the contribution of the P2 and P3 promoters in modulating the activities of the stronger P1 promoter.
Characterization of a sarA deletion mutant construct containing a sarA fragment with an active sarA P1 promoter but
inactive P2 and P3 promoters. In our previous studies, we
found that a sarA fragment containing the native triple promoter together with the sarA coding region was able to complement a sarA transposon mutant, ALC136 (3). However,
deletion analysis indicated that the sarA P3-P1 promoter and
the intact P2-P3-P1 promoters are more active than the P1
promoter alone (13). We subsequently found that a sarA fragment containing the P2-P3-P1 promoters, but lacking the putative ORF3 sequence (Fig. 1A), on a shuttle plasmid resulted in
a significant decrease in the SarA protein level compared with the
non-deletion-containing control while the effect of deletion of
putative ORF4 nested within the P2-P3 promoter was much less
(7). To differentiate the effect of the putative ORF3 sequence
from those of the P3 and P2 promoters on SarA expression and
to avoid the issue of gene copy number, we undertook a sitedirected mutagenesis approach in which we mutated the ⫺10 and
⫺35 promoter boxes of the sarA P2 and P3 promoters while
leaving the P1 promoter intact. We also separately introduced
stop codons and a deletion of the putative ORF3 sequence (nucleotides 582 to 678) (1) into a similarly sized sarA fragment (Fig.
1A) to examine the effect of a single copy of putative ORF3 on
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FIG. 1. Construction of sarA deletion mutants complemented with various sarA fragments in single copy via integration into the lipase gene
(geh). (A) Schematic representation of the mutated sarA fragment constructs. (B) Northern blot assays of various mutant constructs at mid-log
(optical density [OD] at 650 nm ⫽ 0.7) and early stationary (optical density at 650 nm ⫽ 1.7) phases probed with the sarA gene probe. wt, wild
type.

sarA expression. As the recipient for these mutated fragments, we
constructed a sarA mutant (ALC1342 [⌬orf3sarA::ermC]) with a
deletion of ORF3 and the sarA coding region to ensure that the
genetic background was null for sarA and orf3. Accordingly, the
mutated fragments were cloned into integration vector pCL84
(Tetr) and electroporated into S. aureus strain CYL316, a derivative of RN4220 with the integrase gene provided in trans. Lipasenegative transformants, resulting from integration of recombinant
pCL84 into the lipase gene (12), were selected on tetracycline and
egg yolk agar plates. After Southern confirmation, the correct
transformants were infected with phage 11 and the lysate used
to infect deletion mutant ALC1342 (⌬orf3sarA::ermC) to yield
transductants. The authenticity of the transductants was confirmed by Southern blot assays with tetK and lipase gene probes.
As shown in Fig. 1B, the deletion mutant complemented with a
single copy of the native sarA fragment with mutated P2 and P3
promoters (ALC1880) expressed only the sarA P1 transcript while
the normally complemented mutant (ALC2279) was able to express all three sarA transcripts. As expected, the complemented
mutant carrying a stop codon of the putative ORF3 yielded all
three sarA transcripts (ALC1865) while the corresponding mutant lacking the putative ORF3 sequence had a smaller P3 but an
intact P1 transcript (ALC1864).
Effect of the sarA fragment with an active P1 promoter but
inactive P2 and P3 promoters. To determine if activation of
sarA P1 but not the P2 and P3 promoters would alter SarA
protein expression, we probed an immunoblot of the whole-

cell lysate of the mutant complemented with a sarA fragment
with an active P1 promoter but inactive P2 and P3 promoters
(ALC1880) using monoclonal anti-SarA antibody 1D1 (7). As
shown in Fig. 2, the mutant construct ALC1880 exhibited a

FIG. 2. Immunoblot assay of cell extracts of various sarA mutant
constructs probed with a 1:1,000 dilution of anti-SarA monoclonal
antibody 1D1 and anti-SigB monoclonal antibody 1D1. Densitometric
analysis with the Sigma Gel software revealed the following: wild type,
394 densitometric units; ALC1880, 362 densitometric units; ALC2279,
710 densitometric units. Anti-SigB blotting was done to ensure that
equal amounts of extracts were applied to all of the lanes.
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FIG. 3. Northern blot assays of various sarA mutant constructs with
agr RNAII and RNAIII, hla, sspA, spa, and 16S rRNA gene probes.
Ten micrograms of total RNA, determined by optical density at 260
nm, was applied to each lane of the blot. Lanes 1 to 6: RN6390 (wild
type), ALC1342 (⌬orf3sarA::ermC), ALC1880 (ALC1342 complemented with sarA with mutated P2, mutated P3, and wild-type P1),
ALC1864 (ALC1342 complemented with sarA with wild-type P2, wildtype P3, and wild-type ⌬orf3 P1), ALC1865 (ALC1342 complemented
with sarA with wild-type P2, P3 stop, and wild-type orf3 P1), and
ALC2279 (ALC1342 complemented with sarA with wild-type P2, wildtype P3, and wild-type P1), respectively. The RNAs for the blots for agr
RNAII, RNAIII, and spa were obtained at late log phase, while those
for hla and sspA were harvested during the early stationary phase.

lower SarA level (362 densitometric units) versus the complemented mutant carrying an identically sized fragment with
intact P1, P2, and P3 promoters (ALC2279) expressed SarA
protein at a higher level (710 U). The elevated expression of
SarA, at either the transcription or the protein level in the
complemented strain (ALC2279) compared to wild-type
RN6390, is possibly due to the positional effect of the integration of the sarA P2-P3-P1 fragment, or the sarA gene could be
expressed from an exogenous promoter. However, in the mutant constructs in which the promoters were maintained, but
the putative ORF3 between the P1-P3 promoters was either
deleted (ALC1864) or mutated with nonsense mutations
(ALC1865) (Fig. 1A), the expression of SarA was not significantly altered compared with the complemented mutant
ALC2279. Collectively, these data indicated that the P3 and P2
promoters rather than the sequence encoding putative ORF3
likely contributed to SarA protein expression.
The agr promoters represent some of the target promoters
to which SarA binds (6). As the agr locus comprises two divergent promoters that yield two distinct transcripts designated
RNAII and RNAIII, the expression of these two transcripts in
our mutant constructs was examined. As expected for the sarA
deletion mutant ALC1342, the transcription of RNAII was
reduced compared with complemented sarA mutant strain
ALC2279 or the wild-type strain. Interestingly, in the mutant
ALC1880 with the solely active P1 promoter, agr RNAII transcription was also reduced compared with the complemented
mutant (ALC2279). The complemented strains with those constructs with nonsense mutations or a deletion of the putative
ORF3 sequence (ALC1865 and ALC1864) appeared to enhance RNAII transcription compared with the parent or the
complemented strain (Fig. 3), in concordance with higher levels of SarA expression in these strains (Fig. 2). The effect of the
sarA locus on agr RNAIII was more or less the same as that on
RNAII, with less than the complemented level in ALC1880.
The higher expression of agr RNAIII in the construct with
nonsense mutations or a deletion of the putative ORF3 se-
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quence (ALC1865 and ALC1864) was found compared with
wild-type RN6390.
The regulatory molecule of the sarA locus is the SarA protein. Transcription and DNA-binding studies indicated that
SarA can modulate target gene transcription directly by binding to the target promoter (e.g., hla promoter), as well as
indirectly via impact on an intermediary regulator such as agr
(5, 6, 17). Given that an intact sarA fragment with inactive P2
and P3 promoters (i.e., only P1 is active) in ALC1880 was able
to restore RNAII transcription of the sarA deletion mutant to
near the parental level or less than the complemented strain. It
is likely that the major effect of the P3 and P2 promoters, as
divulged by the consistently lower SarA protein expression in
the mutant ALC1880 versus complemented strain ALC2279,
may be direct on target genes or indirect via agr. To verify this,
we examined the transcription of three divergent target genes,
including hla (alpha-toxin gene), sspA (V8 protease gene), and
spa (protein A gene). The transcription of hla during late log to
early stationary phase, normally diminished in a sarA deletion
mutant, was also reduced in the ALC1880 mutant with the
solely active P1 promoter compared with the parent or the
complemented strain but was restored in the complemented
mutant (ALC2279) and its counterpart with a nonsense mutation in the putative ORF3 sequence (ALC1865). Interestingly,
the mutant construct containing a similar sarA fragment but
lacking the sequence for putative ORF3 (ALC1864) expressed
hla poorly compared with the parent and the complemented
mutant. The expression of sspA encoding V8 protease is normally repressed by sarA (8, 11). As anticipated, the expression
of sspA in the sarA mutant was higher than the parent and the
complemented mutant (ALC2279). However, the mutant carrying the native sarA fragment with only the P1 promoter
(ALC1880) was only partially effective in repressing sspA expression compared with the complemented mutant ALC2279.
Of interest is the finding that the mutant carrying a sarA fragment with a deletion in the putative ORF3 sequence
(ALC1864) was more effective in sspA repression than the
mutant construct ALC1880 but less so than the complemented
mutant (ALC2279) and the mutant containing nonsense mutations in putative ORF3 (ALC1865). Likewise, the expression
of spa, a gene normally repressed by sarA, was elevated in the
sarA deletion mutant but partially repressed by a native sarA
fragment with P1 as the only active promoter (ALC1880). In
contrast, the complemented mutant (ALC2279) and mutants
with a sarA fragment lacking the putative ORF3 sequence
(ALC1864) or containing nonsense mutations in ORF3
(ALC1865) were capable of repressing spa transcription to
almost undetectable levels. These finding are consistent with
the observed SarA protein levels in these strains.
The sarA promoter region is complex, with an extended
promoter region (⬃800 bp) comprising three promoters (P1,
P2, and P3), two putative small coding regions (ORF3 and
ORF4), and multiple direct and indirect repeats within (1). In
previous studies of sarA complementation with multicopy plasmids (4, 10), we determined that the putative ORF3 sequence,
but not that of ORF4, within the sarA promoter is likely to be
important for sarA function. To clarify the role of putative
ORF3 and the importance of the P3 and P2 promoters and the
region upstream of the predominant P1 promoter (13), we
constructed strains with single-copy sarA fragments carrying
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mutations in the P2 and P3 promoter and deletions (97-bp
region containing the ribosome-binding site and the N-terminal 24 residues of ORF3) and nonsense mutations in putative
ORF3 for complementation in a sarA deletion mutant
(ALC1342). Based on our results, several themes emanated
from this study. First, activation of the sarA P2 and P3 promoters serves to augment SarA protein expression (Fig. 2). In
particular, this enhancement effect is not mediated via the sarA
P1 promoter since the P1 promoter activity appeared to be
increased in the mutant ALC1880. As the P2 and P3 transcripts
also encode SarA, it is plausible that loss of both transcripts
would lead to lower SarA expression. Another weak alternative
explanation may be that the P2 and P3 transcripts, which contain many inverted repeats, may play a role in SarA translation.
Second, the finding that nonsense mutations of the putative
ORF3 region in a single-copy sarA fragment with intact P1, P2,
and P3 promoters (ALC1865) did not affect SarA protein
expression or expression of the hla, sspA, and spa genes compared with the complemented mutant indicated that the ORF3
sequence is unlikely to be expressed or is inconsequential in S.
aureus cells. The finding that deletion of this sequence
(ALC1864) led to dysregulation of hla and, to a lesser extent,
sspA (Fig. 3), but we do not know the exact reason. Third, there
was a reduction in the SarA protein level in the mutant construct ALC1880 with inactive P2 and P3 promoters. Therefore,
there was a significant effect on the expression of agr RNAII
and RNAIII compared with the complemented strain, thus
implying that the modest changes in the SarA protein level in
ALC1880 did impact the intermediary regulator agr and altered the expression of target genes such as hla, spa, and sspA.
Fourth, the effect of a modest reduction in the SarA protein
level in ALC1880, due to the inactive P2 and P3 promoters,
could result in significant but divergent modulations of various
target genes. For instance, sspA, a sarA-repressible gene, continued to be expressed in ALC1880 while the remaining mutants were more successful in down-regulating sspA expression.
A similar effect was also observed in the case of spa transcription. Of interest is the finding that hla expression was downregulated to comparable degrees in the sarA deletion mutant
(ALC1342) and the ALC1880 mutant. Although the complemented ALC2279 mutant was able to reestablish hla expression, the mutant with a sarA fragment lacking the putative
ORF3 sequence (ALC1864) expressed hla poorly. This discrepancy may be due to some unknown factor. In addition, it
has also been shown that besides sarA and agr, multiple regulatory systems, including saeRS, sarT, and rot, may also contribute to hla regulation (9, 15, 18). Nevertheless, the regulatory relationship among sae, sarT, and rot and the effect of the
interaction of SarR with these regulators on hla remain poorly
defined.
In a previous study with multicopy plasmids (4), we have
shown that the sequence encoding putative ORF3 is likely
required for agr expression. However, the major drawback of
that study was the increased gene dosage and the limitation
Editor: J. T. Barbieri
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that the P2 and P3 promoters were active in the sarA background. The present study, designed to resolve these issues,
clearly showed that the sarA P2 and P3 promoters have some
effect, whereas putative ORF3 has a minimal effect, on agr
expression. This alteration in agr expression is clearly due to
the effect of the SarA protein level and the ensuing sspA, spa,
and hla expression, probably in both agr-independent and agrdependent manners. Based on our studies of nonsense mutations, we conclude that the putative ORF3 sequence is unlikely
to be translated but may modulate hla, but not sspA and spa,
expression, probably by virtue of its role as a binding site for
regulatory proteins (e.g., SarR).
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